A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
- Conditions
- Seborrheic Dermatitis on the Face
- Interventions
- Drug: Azelaic Acid 15% GelDrug: Inactive 15% gel base
- First Posted Date
- 2006-12-06
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 48
- Registration Number
- NCT00408330
LEO19123 Cream in the Treatment of Hand Eczema
- Conditions
- Hand Eczema
- First Posted Date
- 2006-11-28
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 75
- Registration Number
- NCT00404196
- Locations
- 🇬🇧
Queen's Medical Centre, Nottingham, United Kingdom
A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis
- Conditions
- Perioral Dermatitis
- Interventions
- Drug: Azelaic acid 15% gelDrug: Non-active base from azelaic acid 15% gel
- First Posted Date
- 2006-11-27
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 48
- Registration Number
- NCT00403949
LEO19123 Cream in the Treatment of Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- First Posted Date
- 2006-10-25
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 75
- Registration Number
- NCT00392067
- Locations
- 🇬🇧
Manchester Royal Infirmary, Manchester, United Kingdom
🇨🇦Clinique Dermatologique Maizerets, Quebec City, Quebec, Canada
🇫🇮Helsinki University Central Hospital, Helsinki, Finland
Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
- Conditions
- Psoriasis
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 160
- Registration Number
- NCT00279162
- Locations
- 🇺🇸
Center for Clinical Studies, Houston, Texas, United States
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 541
- Registration Number
- NCT00277394
- Locations
- 🇫🇷
Hôpital de la Cavale Blanche, Brest, France
🇧🇬Bulgaria - managed by CRO, Sofia, Bulgaria
🇨🇿Czech Republic - managed by CRO, Praha, Czechia
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
- Conditions
- Psoriasis Vulgaris
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 360
- Registration Number
- NCT00263718
- Locations
- 🇸🇪
Läkarhuset Vällingby, Vällingby, Sweden
🇩🇪Universitätsklinikum Leipzig, Leipzig, Germany
🇮🇪Waterford Regional Hospital, Waterford, Ireland
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
- Conditions
- Psoriasis Vulgaris
- First Posted Date
- 2005-11-04
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 320
- Registration Number
- NCT00248456
- Locations
- 🇨🇳
Fudan University First Hospital, Dermatology Department, Shanghai, China
Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-10-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 300
- Registration Number
- NCT00243464
- Locations
- 🇧🇪
Universitair Ziekenhuis Sint Raphaël, Dienst Dermatologie, Leuven, Belgium
🇨🇦Windsor Clinical Research Inc., Windsor, Ontario, Canada
🇩🇰Department of Dermatology, Marselisborg Centres, Aarhus, Denmark
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 800
- Registration Number
- NCT00216879
- Locations
- 🇨🇦
Clinique de Dermatologie, Moncton, Canada
🇩🇰Hørsholm Hospital, Dermatological Department, Hørsholm, Denmark
🇬🇧Monklands Hospital, Department of Dermatology, Airdrie, United Kingdom